SpineThera, a privately held, pre-clinical stage pharmaceutical company, announced that Jeff Missling, CEO, will give a company presentation at the BioTech Showcase in San Francisco, CA on Tuesday, 12 Jan 2016 at 4:15 pm. Missling said, "Meeting participants can expect to learn more about our patented micro-suspension, sustained-release corticosteroid technology at this presentation. Our lead product candidate, SX600, is a 505(b)2 drug in development for epidural administration. Physicians routinely administer epidural injections of relatively short-acting generic steroids to treat lumbosacral radiculopathy and other back pain conditions. We aim to develop improved drugs for this underserved market."
Parc 55 Hotel, 55 Cyril Magnin Street, San Francisco, California, USA, 94102
12 Jan 2016, 4:15 pm; Track E-Davidson (4ths Floor)